Reference no: EM133918608

Question

Make an Nursing Care Plan, FDAR at Drug Study based on the given case study

Patient A is a woman, 24 years of age, gravida three para two, went to the clinic for her first prenatal check-up because she believes she is about seven weeks pregnant. Three days previous, she noted some pink vaginal spotting. She presented with painless, dark red vaginal spotting. Patient A reported her last intercourse was more than a week ago. She denied any itching, burning, or malodorous discharge prior to the onset of her symptoms. She denied fever but thinks she had been having chills. Some nausea was reported but no vomiting. She did have a positive home pregnancy test one month ago. She had periods of uterine cramping, and also admitted to some mild upper abdominal cramping. The patient complained of suprapubic pain after urination, rated 5 out of 10. The pain occurred after each voiding. The pain did not localize elsewhere and lasted for just a few minutes. Patient A reported some frequency, but attributed this to her pregnancy. Bowel function has been normal. She was appropriately concerned, as her previous pregnancies were uncomplicated. Patient A has also been treated for recurrent lower urinary tract infection and bacterial vaginosis during the same period of time.

Examination revealed normal external genitalia. The vagina was pink with moderate amounts of maroon colored watery discharge noted. The cervix was pink and appeared closed. No exudate or lesions were noted on the cervix. Bimanual examination revealed a nontender uterus, anteverted, enlarged to a six- to seven-week gestational size. No masses were appreciated. The uterus was normal shape and configuration. The cervix was long and closed. Cervical motion tenderness was absent.

Her hemoglobin was 12.4, with the remainder of her lab work within normal limits. Urinalysis revealed 30 to 40 WBCs per high-powered field, 20 to 30 RBCs, moderate bacteria, moderate epithelial cells, and some casts. A urine sample was forwarded to the lab for culture and sensitivity. The routine pregnancy laboratory tests were obtained, and an ultrasound exam was ordered. The ultrasound revealed a strong fetal heartbeat ranging from 140 to 150 beats per minute (bpm). A gestational sac and yolk sac is also visible. It also revealed periods of uterine cramping. She was advised to have complete bed rest. She was instructed to increase oral fluid intake and to repeat her urinalysis in her next prenatal check-up. She was given Iberet Folic- 500 1-tab OD PO, Duvadilan 10mg 1-tab TID PO, cephalexin 500mg 1 tab every 12 hours PO for 7 days.